EU Clinical Trial 2018-003349-41

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of ST-0529 in Subjects with Moderately to Severely Active Ulcerative Colitis  Feb 19, 2019

Main objective of the trial: The primary efficacy objective is to evaluate the efficacy of ST-0529 in achieving clinical remission in subjects with moderately to severely active ulcerative colitis. The safety objective is to evaluate the safety and tolerability of treatment with ST-0529 in subjects with moderately to severely active UC.

Parties

Sponsors
Countries
BE BG BY CA DE ES GB HU IE IL PL RO RS RU TR UA US
Keywords
CICLOSPORIN ST-0529 Ulcerative colitis

JSON preview

Similar records

Title

Source:  EMA Last updated:  May 30, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.